Autopsy report · NCT03782402

Cannabinoids for Taxane Induced Peripheral Neuropathy

“Funding being sought”

The sponsor’s own words in the registry.

Life of this trial

• Registered 8 months before it started.
• Ran for about 2 years before it stopped.
• 12 participants enrolled.
• Results were posted on the registry 1 year 5 months after it ended.

Vital statistics

Status

Terminated

Phase

Phase 2

Sponsor

New York State Psychiatric Institute

Sponsor type

University, hospital or other

Conditions

Chemotherapy-induced Peripheral Neuropathy

Interventions

Cannabinoids

Participants

12

Sites

1

Countries

United States

Trials that died the same way

• IRIS-BioFreedom Cohort in the IRIS-DES Registry
  “Funding issue” (82% match in meaning)
• Prognostic Assessment of Different Pattern of Bifurcation Restenosis
  “Funding issues” (81% match in meaning)
• Smartphone-enabled Health Coaching Intervention for Youth Diagnosed With Major Depressive Disorders
  “New funding required” (80% match in meaning)
• WeArable Neuromodulation DeVice for the TrEatment of Alzheimer's Disease
  “funding purposes” (79% match in meaning)
• Amplification of Positivity for Alcohol Use Disorder Co-Occurring With Anxiety or Depression
  “Limited funding” (77% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.